Wolfgang Weber, MD, presented “Molecular Imaging of Prostate Cancer” during the 4th Global Summit on Precision Diagnosis and Treatment of Prostate Cancer on October 3, 2019 in Boston, Massachusetts.
How to cite: Weber, Wolfgang. “Molecular Imaging of Prostate Cancer” October 3, 2019. Accessed Nov 2024. https://dev.grandroundsinurology.com/molecular-imaging-of-prostate-cancer/
Molecular Imaging of Prostate Cancer – Summary:
Wolfgang Weber, MD, Professor and Chair of the Department of Nuclear Medicine at the Technical University of Munich in Germany, discusses the changes in molecular imaging over the last 7 years and their impact on staging and re-staging of prostate cancer. Dr. Weber discusses how PSMA PET imaging works by binding with the ligands of antigens present in cells affected by prostate cancer. He also describes studies in which molecular imaging has been useful in reclassifying nmCRPC by identifying metastases not visible using conventional imaging, specifically in bones and lymph nodes. This has led to novel theranostic approaches where imaging closely intertwines with surgery or chemotherapy to potentially improve treatment outcomes.
About The 4th Global Summit on Precision Diagnosis and Treatment of Prostate Cancer:
The Global Summit on Precision Diagnosis and Treatment of Prostate Cancer is a multi-day, multi-disciplinary forum designated to inform health care stakeholders about topics including in-vitro fluid- and tissue-based molecular diagnostics, novel observation strategies such as active surveillance, and novel therapeutic interventions. Along with this forum’s efforts to form a consensus on the future of prostate diagnostics and precision care, it aims to create an educational and research strategy for its realization. Dr. Weber presented this lecture during the 4th iteration of this summit in 2019.
ABOUT THE AUTHOR
Wolfgang Weber, MD, is Professor and Chair of the Department of Nuclear Medicine at the Technical University of Munich in Germany (TUM). Dr. Weber graduated from and trained at TUM. He has been an Associate Professor in the Department of Molecular and Medical Pharmacology at the University of California, Los Angeles; Professor and Chair of the Department of Nuclear Medicine at the University of Freiburg in Freiburg im Breisgau, Germany; Chief of Nuclear Medicine at Memorial Sloan-Kettering Cancer Center in New York City; and Professor of Radiology at Weill-Cornell Medical College, also in New York City. He focuses on molecular imaging of cancer for therapeutic interventions, and is interested in targeted radionuclide therapy and theranostics. Dr. Weber has published 250+ papers in numerous journals, including the Journal of Nuclear Medicine, the European Journal of Nuclear Medicine and Molecular Imaging, the Journal of Clinical Oncology, and others. He has also served on the editorial boards of several medical journals.
